Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data

Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 57.22 --0 (-0%)
Previous Close $57.22    52 Week High $17.00 
Open $57.22    52 Week Low $3.55 
Day High $57.22    P/E N/A 
Day Low $57.22    EPS $-1.33 
Volume 13,005